CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,855 enrolled
Drug / intervention
EHR-integrated Shared Decision Making Tool and Clinical Decision Support for Lung Cancer Screeningother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04498052
NCT04498052N/ACompleted

Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening

University of Utah·interventional·Posted Aug 4, 2020·Updated Mar 24, 2025

In Brief

A clinical study evaluating EHR-integrated Shared Decision Making Tool and Clinical Decision Support for Lung Cancer Screening for Early Detection of Cancer and Lung Neoplasms. Completed, enrolled 1,855 participants across 1 site.

Detailed Summary

The purpose of this project is to increase appropriate low-dose computed tomography (LDCT) lung cancer screening through the development and wide dissemination of patient-centered clinical decision support (CDS) tools that (1) are integrated with the electronic health record (EHR) and clinical workflows, (2) prompt for shared decision making (SDM) when patients meet screening criteria, and (3) enable effective SDM using individually-tailored information on the potential benefits and harms of screening. The study will promote standard of care that is endorsed by the Centers for Medicare \& Medicaid Services (CMS) and the US Preventive Services Task Force (USPSTF).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 4, 2020
Enrollment StartAug 23, 2020
Primary CompletionApr 27, 2022
Study CompletionDec 4, 2024
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.9 years ago

Interventions

EHR-integrated Shared Decision Making Tool and Clinical Decision Support for Lung Cancer Screeningother

The intervention will consist of the following core items: In period 1: * An EHR-integrated shared decision making (SDM) tool for providing information on the risks and benefits of lung cancer screening through low-dose computed tomography (LDCT) testing. This intervention is referred to as Decision Precision+. * Suggestions in the EHR to offer SDM for LDCT for patients eligible for lung cancer screening according to USPSTF guidelines. These suggestions include those provided by the EHR's "Health Maintenance" module as well as an EHR-integrated "Disease Manager" system for disease management and health maintenance. In period 2: \- Same as period 1 + simple patient reminders in the patient portal. Following roll-out, clinic leaders may also receive periodic feedback on use of the intervention and LDCT screening rates, as well as advice on how to improve intervention adoption.